Drug class in one race
CDK2 drugs for HR+/HER2- Metastatic Breast Cancer
4 tracked CDK2 drugs in the HR+/HER2- Metastatic Breast Cancer race. The class explanation lives on the CDK2 page; the full indication pipeline across every mechanism is on the HR+/HER2- Metastatic Breast Cancer page.
3 Phase 1/21 Phase 1